CatalystWireBeta

Form 8 (DD) - Futura Medical

In brief · summary, not quotable

Benjamin Turner, James Pope, and close relatives, acting as connected advisers to Futura Medical plc, have disclosed dealings in the company's ordinary shares. Following a firm placing, they now own or control 21,749,999 ordinary shares, representing 3.40% of the company, and have received 18,749,999 shares at a price of 0.2 each. They also hold rights to subscribe for 34,125,000 2025 Warrants and 163,625,000 2026 Warrants. This disclosure amends a previous RNS and was made on 07 October 2026.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes

Amendment – this form replaces RNS 3128U, published at 16:40 on 10/09/26. Changes have been made to Sections 2(b).

KEY INFORMATION

(a) Full name of discloser:Benjamin Turner, James Pope & close relatives
(e) Date dealing undertaken:09.09.2026
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
Class of relevant security:Ordinary shares of 0.2p each
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:21,749,9993.40%
  • Cash-settled derivatives:
  • Stock-settled derivatives (including options) and agreements to purchase/sell:
(a) Full name of discloser:Benjamin Turner, James Pope & close relatives
TOTAL:21,749,9993.40%

All interests and all short positions should be disclosed.

  • Rights to subscribe for new securities (including directors’ and other employee options)
Class of relevant security in relation to which subscription right exists:2025 Warrants
Details, including nature of the rights concerned and relevant percentages:34,125,000
Class of relevant security in relation to which subscription right exists:2026 Warrants
Details, including nature of the rights concerned and relevant percentages:163,625,000

DEALINGS BY THE PERSON MAKING THE DISCLOSURE

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Class of relevant securityPurchases/ salesTotal number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
(b) Cash-settled derivative transactions
Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
(ii) Exercise
Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
(d) Other dealings (including subscribing for new securities)
Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
Ordinary sharesReceival of Shares – Firm Placing18,749,9990.2
  • OTHER INFORMATION
  • Indemnity and other dealing arrangements

None

  • Agreements, arrangements or understandings relating to options or derivatives

None

Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)NO
Supplemental Form 8 (SBL)NO
Date of disclosure:07.10.2026

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note